Skip to main content
GutCited

Psyllium Husk لـ Irritable Bowel Syndrome (IBS)

B الأدلة تدعم ذلك تجربة عشوائية واحدة على الأقل، مع نتائج متسقة في معظمها.

ACG recommends soluble fiber (psyllium) over insoluble fiber for IBS. Improves global IBS symptoms with particular benefit in IBS-C. NNT of 7 for global symptom improvement.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dpsyllium\u002Dhusk\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

الخلاصة

ACG recommends soluble fiber (psyllium) over insoluble fiber for IBS. Improves global IBS symptoms with particular benefit in IBS-C. NNT of 7 for global symptom improvement.

Key Study Findings

Observational Study n=97
Survey of Latin American gastroenterologists, specialists in disorders of gut-brain interaction, on the diagnosis and …
Dose: None مقابل: None Outcome: IBS management heterogeneity in Latin America التأثير: None None

المجتمع المدروس: Latin American gastroenterologists (DGBI specialists)

Review
The role of dietary fiber in the gastrointestinal tract: when, how and why?
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: Review of dietary fiber role in GI tract

Review
The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention …
Dose: None مقابل: None Outcome: Colitis severity التأثير: None None

المجتمع المدروس: Ulcerative colitis patients

Randomized Controlled Trial n=314
Sex-Dependent Efficacy of Dietary Fiber in Pediatric Functional Abdominal Pain.
Dose: Dietary fiber (psyllium) مقابل: Low fiber diet Outcome: Abdominal pain frequency التأثير: None None

المجتمع المدروس: Children with functional abdominal pain disorders

Randomized Controlled Trial 3 weeks Double-blind
Nutraceuticals and Pain Disorders of the Gut-Brain Interaction in Infants and Children: A Narrative Review …
Dose: None مقابل: Placebo Outcome: Pain outcomes التأثير: None None

المجتمع المدروس: IBS patients

Systematic Review
[Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review].
Dose: Peppermint oil, STW-5, psyllium, others مقابل: Standard care or placebo Outcome: Symptom improvement in GI diseases التأثير: None None

المجتمع المدروس: Patients with gastroenterological diseases

Key Statistics

8

الدراسات

900

المشاركون

↑

Positive

B

التقييم

Referenced Papers

The Medical letter … 2025
Current opinion in … 2021 6 اقتباسات
The Medical letter … 2020
International journal of … 2017 146 اقتباسات
Journal of gastroenterology … 2017 32 اقتباسات
Current opinion in … 2017 24 اقتباسات
International journal of … 2016 69 اقتباسات
Clinical gastroenterology and … 2016 2 اقتباسات
Digestion 2014 61 اقتباسات
The American journal … 2013 421 اقتباسات
Journal of clinical … 2011 30 اقتباسات
Alimentary pharmacology & … 2011 3 اقتباسات
Current opinion in … 2010 22 اقتباسات
Australian family physician 2009 12 اقتباسات
International journal of … 2007 375 اقتباسات
Current treatment options … 2006 24 اقتباسات
Alimentary pharmacology & … 2004 322 اقتباسات
Biomedicine & pharmacotherapy … 1986 4 اقتباسات
Annals of internal … 1981 91 اقتباسات
Annals of internal … 1981 6 اقتباسات
JAMA 1964

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
5-10 g/day (with adequate water)
ibssupport:
5-10 g/day (start low, titrate up over 1-2 weeks)
constipation:
10-20 g/day in divided doses with at least 240 mL water per dose

الحد الأعلى: Well-tolerated up to 30 g/day with adequate fluid intake

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Mixed 97
None -- Mixed --
None -- Positive --
Dietary fiber (psyllium) -- Positive 314
None 3 weeks Positive --
Peppermint oil, STW-5, psyllium, others -- Positive --
None -- Mixed --
Low-FODMAP, probiotics, fiber -- Positive --

أفضل وقت للتناول: With meals and a full glass of water (240 mL minimum); space 1-2 hours from medications

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • ⚠ Gas and bloating (common initially; start with low dose and titrate up)
  • ⚠ Esophageal/bowel obstruction if taken without adequate water (CRITICAL: always take with full glass of water)
  • ⚠ Abdominal cramping at high initial doses
  • ⚠ May reduce appetite (feeling of fullness)

التفاعلات المعروفة

  • ● May reduce absorption of medications if taken simultaneously (space 1-2 hours)
  • ● Lithium (reduced absorption)
  • ● Carbamazepine (reduced absorption)
  • ● Diabetes medications (may enhance blood sugar lowering; monitor glucose)

الحد الأقصى المسموح به: Well-tolerated up to 30 g/day with adequate fluid intake

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Psyllium Husk help with Irritable Bowel Syndrome (IBS)?
Based on 8 studies with 900 participants, there is moderate evidence from clinical studies that Psyllium Husk may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Psyllium Husk should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 5-10 g/day (with adequate water). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Psyllium Husk?
Reported side effects may include Gas and bloating (common initially; start with low dose and titrate up), Esophageal/bowel obstruction if taken without adequate water (CRITICAL: always take with full glass of water), Abdominal cramping at high initial doses, May reduce appetite (feeling of fullness). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Psyllium Husk and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 8 peer-reviewed studies with 900 total participants. The overall direction of effect is positive.

References

  1. [1] Christian von Muhlenbrock et al.. Best Pract Res Clin Gastroenterol. 2025. The role of dietary fiber in the gastrointestinal tract: when, how and why? doi:10.1016/j.bpg.2025.102080 PubMed
  2. [2] . Med Lett Drugs Ther. 2025. Comparison chart: Some drugs for irritable bowel syndrome with constipation (IBS-C). doi:10.58347/tml.2025.1721e PubMed
  3. [3] . Med Lett Drugs Ther. 2025. Drugs for irritable bowel syndrome. doi:10.58347/tml.2025.1721a PubMed
  4. [4] I Hanna-Jairala et al.. Rev Gastroenterol Mex (Engl Ed). 2025. Survey of Latin American gastroenterologists, specialists in disorders of gut-brain interaction, on the diagnosis and treatment of irritable bowel syndrome … doi:10.1016/j.rgmxen.2025.10.001 PubMed
  5. [5] . Med Lett Drugs Ther. 2025. Comparison chart: Some drugs for irritable bowel syndrome with diarrhea (IBS-D). doi:10.58347/tml.2025.1721f PubMed
  6. [6] Pankaj Garg et al.. Gastroenterology. 2024. Psyllium Husk Positively Alters Gut Microbiota, Decreases Inflammation, and Has Bowel-Regulatory Action, Paving the Way for Physiologic Management of Irritable … doi:10.1053/j.gastro.2023.11.019 PubMed
  7. [7] Silvia Salvatore et al.. Nutrients. 2024. Nutraceuticals and Pain Disorders of the Gut-Brain Interaction in Infants and Children: A Narrative Review and Practical Insights. doi:10.3390/nu16030349 PubMed
  8. [8] Justyna Przybyszewska et al.. Prz Gastroenterol. 2024. The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal … doi:10.5114/pg.2024.139209 PubMed
  9. [9] Sandra Utz et al.. Z Gastroenterol. 2024. [Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review]. doi:10.1055/a-2279-5045 PubMed
  10. [10] Sik Yu So et al.. Gastroenterology. 2024. Sex-Dependent Efficacy of Dietary Fiber in Pediatric Functional Abdominal Pain. doi:10.1053/j.gastro.2023.12.011 PubMed
  11. [11] Silvia Salvatore et al.. Nutrients. 2023. Dietary Fibers in Healthy Children and in Pediatric Gastrointestinal Disorders: A Practical Guide. doi:10.3390/nu15092208 PubMed
  12. [12] Richard Gearry et al.. Am J Gastroenterol. 2023. Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort-Results of an International Multicenter Randomized Controlled Trial. doi:10.14309/ajg.0000000000002124 PubMed
  13. [13] Marcelina Radziszewska et al.. Nutrients. 2023. Nutrition, Physical Activity and Supplementation in Irritable Bowel Syndrome. doi:10.3390/nu15163662 PubMed
  14. [14] Jagadeesh Menon et al.. J Pediatr Gastroenterol Nutr. 2023. Efficacy of Oral Psyllium in Pediatric Irritable Bowel Syndrome: A Double-Blind Randomized Control Trial. doi:10.1097/MPG.0000000000003622 PubMed
  15. [15] Daniela Pop et al.. Nutrients. 2023. The Use of Fibers, Herbal Medicines and Spices in Children with Irritable Bowel Syndrome: A Narrative Review. doi:10.3390/nu15204351 PubMed
  16. [16] Miranda A L van Tilburg et al.. J Pediatr Gastroenterol Nutr. 2023. Efficacy of Oral Psyllium in Pediatric Irritable Bowel Syndrome: A Double-Blind Randomized Control Trial. doi:10.1097/MPG.0000000000003814 PubMed
  17. [17] Blake J Purtle et al.. Ann Intern Med. 2023. In persons with constipation or IBS-C, kiwifruit vs. psyllium increased spontaneous bowel movements. doi:10.7326/J23-0022 PubMed
  18. [18] David Gunn et al.. Gut. 2022. Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies. doi:10.1136/gutjnl-2021-324784 PubMed
  19. [19] Andrew Thomas et al.. Am J Lifestyle Med. 2022. Dietary Modification for the Restoration of Gut Microbiome and Management of Symptoms in Irritable Bowel Syndrome. doi:10.1177/15598276211012968 PubMed
  20. [20] Diego Currò. Expert Rev Gastroenterol Hepatol. 2022. Current evidence on the therapeutic use of fiber in irritable bowel syndrome. doi:10.1080/17474124.2021.1924057 PubMed
  21. [21] Pankaj Garg. Turk J Gastroenterol. 2021. Inflammation in Irritable Bowel Syndrome (IBS): Role of Psyllium Fiber Supplementation in Decreasing Inflammation and Physiological Management of IBS. doi:10.5152/tjg.2020.20229 PubMed
  22. [22] Teodora Surdea-Blaga et al.. Curr Opin Gastroenterol. 2021. Dietary interventions and irritable bowel syndrome - what really works? doi:10.1097/MOG.0000000000000706 PubMed
  23. [23] Christopher J Black et al.. Lancet Gastroenterol Hepatol. 2020. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. doi:10.1016/S2468-1253(19)30324-3 PubMed
  24. [24] . Med Lett Drugs Ther. 2020. Drugs for Irritable Bowel Syndrome. PubMed
  25. [25] Paul Moayyedi et al.. J Can Assoc Gastroenterol. 2019. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). doi:10.1093/jcag/gwy071 PubMed
  26. [26] Liang Dai et al.. World J Clin Cases. 2019. Irritable bowel syndrome and functional constipation management with integrative medicine: A systematic review. doi:10.12998/wjcc.v7.i21.3486 PubMed
  27. [27] Magdy El-Salhy et al.. Int J Mol Med. 2017. Dietary fiber in irritable bowel syndrome (Review). doi:10.3892/ijmm.2017.3072 PubMed
  28. [28] Diego Currò et al.. Br J Pharmacol. 2017. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. doi:10.1111/bph.13632 PubMed
  29. [29] Robert J Shulman et al.. Clin Gastroenterol Hepatol. 2017. Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial. doi:10.1016/j.cgh.2016.03.045 PubMed
  30. [30] Emma P Halmos. J Gastroenterol Hepatol. 2017. When the low FODMAP diet does not work. doi:10.1111/jgh.13701 PubMed
  31. [31] Eirini Dimidi et al.. Curr Opin Clin Nutr Metab Care. 2017. Irritable bowel syndrome and diet: where are we in 2018? doi:10.1097/MCO.0000000000000416 PubMed
  32. [32] Monica R P Rao et al.. Int J Biol Macromol. 2016. Phosphorylation of psyllium seed polysaccharide and its characterization. doi:10.1016/j.ijbiomac.2015.12.043 PubMed
  33. [33] Daniël R Hoekman et al.. Clin Gastroenterol Hepatol. 2016. Should We Treat Our Pediatric Irritable Bowel Syndrome Patients With Psyllium? doi:10.1016/j.cgh.2016.06.001 PubMed
  34. [34] Katy E Trinkley et al.. Digestion. 2014. Medication management of irritable bowel syndrome. doi:10.1159/000362405 PubMed
  35. [35] Shanti Eswaran et al.. Am J Gastroenterol. 2013. Fiber and functional gastrointestinal disorders. doi:10.1038/ajg.2013.63 PubMed
  36. [36] K E Trinkley et al.. J Clin Pharm Ther. 2011. Treatment of irritable bowel syndrome. doi:10.1111/j.1365-2710.2010.01177.x PubMed
  37. [37] E P Halmos et al.. Aliment Pharmacol Ther. 2011. Dried plums, constipation and the irritable bowel syndrome. doi:10.1111/j.1365-2036.2011.04719.x PubMed
  38. [38] Laura E Chouinard. Can J Diet Pract Res. 2011. The role of psyllium fibre supplementation in treating irritable bowel syndrome. doi:10.3148/72.1.2011.48 PubMed
  39. [39] Eduard Cabré. Curr Opin Clin Nutr Metab Care. 2010. Irritable bowel syndrome: can nutrient manipulation help? doi:10.1097/MCO.0b013e32833b6471 PubMed
  40. [40] C J Bijkerk et al.. BMJ. 2009. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. doi:10.1136/bmj.b3154 PubMed
  41. [41] Marie Pirotta. Aust Fam Physician. 2009. Irritable bowel syndrome - The role of complementary medicines in treatment. PubMed
  42. [42] . Prescrire Int. 2009. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment. PubMed
  43. [43] Alexander C Ford et al.. BMJ. 2008. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. doi:10.1136/bmj.a2313 PubMed
  44. [44] Baljit Singh. Int J Pharm. 2007. Psyllium as therapeutic and drug delivery agent. doi:10.1016/j.ijpharm.2007.01.028 PubMed
  45. [45] Reyhaneh Vejdani et al.. Dig Dis Sci. 2006. The efficacy of an herbal medicine, Carmint, on the relief of abdominal pain and bloating in patients with irritable bowel … doi:10.1007/s10620-006-9079-3 PubMed
  46. [46] Howard Y Chang et al.. Curr Treat Options Gastroenterol. 2006. Current gut-directed therapies for irritable bowel syndrome. doi:10.1007/s11938-006-0013-8 PubMed
  47. [47] C J Bijkerk et al.. Aliment Pharmacol Ther. 2004. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. doi:10.1111/j.0269-2813.2004.01862.x PubMed
  48. [48] A Prior et al.. Gut. 1987. Double blind study of ispaghula in irritable bowel syndrome. doi:10.1136/gut.28.11.1510 PubMed
  49. [49] A Prior et al.. Biomed Pharmacother. 1986. Management of irritable bowel syndrome. PubMed
  50. [50] G F Longstreth et al.. Ann Intern Med. 1981. Psyllium therapy in the irritable bowel syndrome. A double-blind trial. doi:10.7326/0003-4819-95-1-53 PubMed
  51. [51] D S Greenbaum et al.. Ann Intern Med. 1981. Psyllium and the irritable bowel syndrome. doi:10.7326/0003-4819-95-5-660_1 PubMed
  52. [52] A P KLOTZ. JAMA. 1964. IRRITABLE COLON. PubMed

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.